Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 8, 2024

Total Value: $205M (100.0% shares, 0.0% debt)

Holdings (7)

ULCC FRONTIER GROUP HLDGS INC 73.4%

Value $150M Shares 28,061,351 Share Price $5.35 Est. Cost/Share $5.99 Unrealized @ Report Date -10.7%

RLX RLX TECHNOLOGY INC 16.0%

Value $32.66M Shares 18,046,195 Share Price $1.81 Est. Cost/Share $5.25 Unrealized @ Report Date -65.5%

ALLO ALLOGENE THERAPEUTICS INC 4.0%

Value $8.178M Shares 2,920,787 Share Price $2.80 Est. Cost/Share $17.44 Unrealized @ Report Date -83.9%

URGN UROGEN PHARMA LTD 3.1%

Value $6.294M Shares 495,606 Share Price $12.70 Est. Cost/Share $34.01 Unrealized @ Report Date -62.7%

— SKILLZ INC 2.7%

Value $5.507M Shares 979,848 Share Price $5.62 Est. Cost/Share $19.79 Unrealized @ Report Date —

— KRONOS BIO INC 0.6%

Value $1.298M Shares 1,297,959 Share Price $1.00 Est. Cost/Share $29.87 Unrealized @ Report Date —

— SILEXION THERAPEUTICS CORP 0.3%

Value $536K Shares 1,020,852 Share Price $0.52 Est. Cost/Share $0.52 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
ULCC	FRONTIER GROUP HLDGS INC	28,061,351	$150M	73.4%	$5.35	$5.99	-10.7%	COM	35909R108
RLX	RLX TECHNOLOGY INC	18,046,195	$32.66M	16.0%	$1.81	$5.25	-65.5%	SPONSORED ADS	74969N103
ALLO	ALLOGENE THERAPEUTICS INC	2,920,787	$8.178M	4.0%	$2.80	$17.44	-83.9%	COM	019770106
URGN	UROGEN PHARMA LTD	495,606	$6.294M	3.1%	$12.70	$34.01	-62.7%	COM	M96088105
—	SKILLZ INC	979,848	$5.507M	2.7%	$5.62	$19.79	—	COM	83067L109
—	KRONOS BIO INC	1,297,959	$1.298M	0.6%	$1.00	$29.87	—	COM	50107A104
—	SILEXION THERAPEUTICS CORP	1,020,852	$536K	0.3%	$0.52	$0.52	—	SHS	G1281K106